pharma · Diabetes Mellitus · Hemophilia A
Takeda
Takeda clinical programs — 154 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 1993
- Employees
- 1,617
- Programs
- 1179
- Drugs
- 359
- Patents
- 1436
Takeda projects
154 ClinicalTrials.gov programs sponsored by Takeda.
Takeda has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
pioglitazone
Takeda
Type 2 Diabetes Mellitus
4 trials -
pioglitazone
Takeda
Type 2 Diabetes
1 trial -
placebo
Takeda
Constipation
1 trial -
prucalopride
Takeda
Chronic Constipation
1 trial -
ramelteon
Takeda
Migraine Headache
1 trial -
rhPTH (1-84)
Takeda
Hypoparathyroidism
3 trials -
rhPTH(1-84)
Takeda
Chronic Hypoparathyroidism
2 trials -
rt-PA
Takeda
Lacunar Stroke
1 trial -
theophylline
Takeda
Healthy
1 trial -
vortioxetine
Takeda
Depression
1 trial
Frequently asked questions
How many clinical projects does Takeda have?
154 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.